Skip to main content

Table 4 Independent predictors of 30-day mortality in patients with suspected VAP

From: Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study

 

Hazard ratio

95% CI

P

Steroids during VAP

1.93

1.25-2.98

<0.01

Cirrhosis

3.72

1.83-4.31

<0.01

Age

1.02

1.01-1.04

<0.01

SAPS II

1.02

1.01-1.04

<0.01

SOFA day 1

1.15

1.07-1.23

<0.01

Statin prior exposure

1.23

0.79-1.90

0.36

  1. VAP, ventilator-associated pneumonia; CI, confidence interval; SAPS II, simplified acute physiology score II; SOFA, sequential organ failure assessment.